Rapid detection of HLA-A *31:01 allele in DNA and blood samples using loop-mediated isothermal amplification

British Journal of Dermatology

Volumn 171, Issue 1, 2014, Pages 90-96

  Cheung, Y K ^a   Kwok, M ^a   Chan, E ^a   Kwan, P ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; DNA; GENOMIC DNA; HLA A ANTIGEN; ANTICONVULSIVE AGENT; BIOLOGICAL MARKER; HLA-A31 ANTIGEN;

ALLELE; ANTICONVULSANT THERAPY; ARTICLE; B LYMPHOCYTE; BLOOD SAMPLING; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CROSS REACTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DNA DETERMINATION; DNA PURIFICATION; DNA SEQUENCE; DRUG EFFICACY; DRUG SAFETY; EPILEPSY; GENE FREQUENCY; GENOTYPE; HLA TYPING; HUMAN; HUMAN CELL; LOOP MEDIATED ISOTHERMAL AMPLIFICATION; NUCLEOTIDE SEQUENCE; PREDICTIVE VALUE; PRIORITY JOURNAL; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS; SKIN MANIFESTATION; TURNAROUND TIME; BLOOD; CELL LINE; DRUG ERUPTIONS; EARLY DIAGNOSIS; EVALUATION STUDY; FEASIBILITY STUDY; GENETICS; HETEROZYGOTE DETECTION; HOSPITAL INFORMATION SYSTEM; NUCLEIC ACID AMPLIFICATION; PROCEDURES;

ALLELES; ANTICONVULSANTS; BIOLOGICAL MARKERS; CARBAMAZEPINE; CELL LINE; DNA; DRUG ERUPTIONS; EARLY DIAGNOSIS; EPILEPSY; FEASIBILITY STUDIES; HETEROZYGOTE DETECTION; HLA-A ANTIGENS; HUMANS; NUCLEIC ACID AMPLIFICATION TECHNIQUES; POINT-OF-CARE SYSTEMS; SENSITIVITY AND SPECIFICITY;

EID: 84904972033     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.12897     Document Type: Article

References (26)

1. Hung SI, Chung WH, Jee SH, et al,. Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions. Pharmacogenet Genomics 2006; 16: 297-306.
2. McCormack M, Alfirevic A, Bourgeois S, et al,. HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans. N Engl J Med 2011; 364: 1134-43.
3. Ozeki T, Mushiroda T, Yowang A, et al,. Genome-wide association study identifies HLA-A*3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population. Hum Mol Genet 2011; 20: 1034-41.
4. Kim SH, Lee KW, Song WJ, et al,. Carbamazepine-induced severe cutaneous adverse reactions and HLA genotypes in Koreans. Epilepsy Res 2011; 97: 190-7.
5. Genin E, Chen DP, Hung SI, et al,. HLA-A*3101 is more strongly associated with carbamazepine-induced drug reaction with eosinophilia and systemic symptoms than with carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis. Presented at: Drug Hypersensitivity Meeting (DHM5 2012), 11-14 April 2012, Munich, Germany. (Abstr).
6. Lam YWF,. Scientific challenges and implementation barriers to translation of pharmacogenomics in clinical practice. ISRN Pharmacol 2013; 2013: 641089.
7. Middleton D,. History of DNA typing for the human MHC. Rev Immunogenet 1999; 1: 135-56.
8. Cheng SH, Kwan P, Ng HK, Ng MH,. New testing approach in HLA genotyping helps overcome barriers in effective clinical practice. Clin Chem 2009; 55: 1568-72.
9. Notomi T, Okayama H, Masubuchi H, et al,. Loop-mediated isothermal amplification of DNA. Nucleic Acids Res 2000; 28: E63.
10. Ryu KH, Choi SH, Lee JS,. Restriction primers as short as 6-mers for PCR amplification of bacterial and plant genomic DNA and plant viral RNA. Mol Biotechnol 2000; 14: 1-3.
11. Gonzalez-Galarza FF, Christmas S, Middleton D, Jones AR,. Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations. Nucleic Acids Res 2011; 39: D913-19.
12. Flahault A, Cadilhac M, Thomas G,. Sample size calculation should be performed for design accuracy in diagnostic test studies. J Clin Epidemiol 2005; 58: 859-62.
13. Li J, Qu J, Zhang X, et al,. Characterization of 236 novel alleles at the HLA-A, -B, -C, -DRB1, -DQB1 and -DPB1 loci from China Marrow Donor Program. Tissue Antigens 2011; 78: 267-70.
14. Middleton D, Hawkins BR, Williams F, et al,. HLA class I allele distribution of a Hong Kong Chinese population based on high-resolution PCR-SSOP typing. Tissue Antigens 2004; 63: 555-61.
15. Chung WH, Hung SI, Hong HS, et al,. Medical genetics: a marker for Stevens-Johnson syndrome. Nature 2004; 428: 486.
16. Man CB, Kwan P, Baum L, et al,. Association between HLA-B1502 allele and antiepileptic drug-induced cutaneous reactions in Han Chinese. Epilepsia 2007; 48: 1015-18.
17. Locharernkul C, Loplumlert J, Limotai C, et al,. Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B1502 allele in Thai population. Epilepsia 2008; 49: 2087-91.
18. Mehta TY, Prajapati LM, Mittal B, et al,. Association of HLA-B1502 allele and carbamazepine-induced Stevens-Johnson syndrome among Indians. Indian J Dermatol Venereol Leprol 2009; 75: 579-82.
19. Tassaneeyakul W, Tiamkao S, Jantararoungtong T, et al,. Association between HLA-B1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population. Epilepsia 2010; 51: 926-30.
20. Wu XT, Hu FY, An DM, et al,. Association between carbamazepine-induced cutaneous adverse drug reactions and the HLA-B1502 allele among patients in central China. Epilepsy Behav 2010; 19: 405-8.
21. Chang CC, Too CL, Murad S, Hussein SH,. Association of HLA-B1502 allele with carbamazepine-induced toxic epidermal necrolysis and Stevens-Johnson syndrome in the multi-ethnic Malaysian population. Int J Dermatol 2011; 50: 221-4.
22. Wang Q, Zhou JQ, Zhou LM, et al,. Association between HLA-B1502 allele and carbamazepine-induced severe cutaneous adverse reactions in Han people of southern China mainland. Seizure 2011; 20: 446-8.
23. Zhang Y, Wang J, Zhao LM, et al,. Strong association between HLA-B1502 and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in mainland Han Chinese patients. Eur J Clin Pharmacol 2011; 67: 885-7.
24. Cheung YK, Cheng SH, Chan EJ, et al,. HLA-B alleles associated with severe cutaneous reactions to antiepileptic drugs in Han Chinese. Epilepsia 2013; 54: 1307-14.
25. Food and Drug Administration. Information for Healthcare Professionals: Dangerous or Even Fatal Skin Reactions-Carbamazepine (marketed as Carbatrol, Equetro, Tegretol, and generics), 12 December 2007. Available at: http://www.fda.gov/Drugs/DrugSafety/ PostmarketdrugsafetyinformationforPatientsandProviders/ucm124718.htm (last accessed 26 March 2014).
26. Amstutz U, Ross CJ, Castro-Pastrana LI, et al,. HLA-A 31:01 and HLA-B 15:02 as genetic markers for carbamazepine hypersensitivity in children. Clin Pharmacol Ther 2013; 94: 142-9.